Pages
Prem Singh – reflections from a career in public service
https://dchs.nhs.uk/news/prem-singh-reflections-career-public-service
Finance and Procurement System Changes
The Trust’s current contract for the provision of financial services (i.e. finance and procurement) from NHS Shared Business Services (SBS) is coming to an end on 31 March 2022.
https://dchs.nhs.uk/my_dchs/show-me/staff-news-my-download/finance-and-procurement-system-changes
Key handover marks end of construction on Bakewell’s new health centre
https://dchs.nhs.uk/news/key-handover-marks-end-construction-bakewells-new-health-centre
Training - Making inclusive decisions
https://dchs.nhs.uk/my_dchs/show-me/staff-news-my-download/training-making-inclusive-decisions
Derbyshire’s innovative oral health programme for care homes wins national award
https://dchs.nhs.uk/news/derbyshires-innovative-oral-health-programme-care-homes-wins-national-award
Files
A2a - DEPRIVATION OF LIBERTY SAFEGUARDS FORM 1 (P35)
Safeguarding Form 1,P35,DoLs
A1 - Definitions and an Explanation of Terms Used (P10)
PEOPLE DEVELOPMENT LEARNING CONTRACT - Learning Expectations.docx
A3 - SBARD Structured Communication Tool
Disclosure Ref 2024153 - 65 week wait for elective treatment .pdf
Disclosure Ref 2025151 - Trust buying and supplying paracetamol and Ibuprofen.pdf
FOI disclosure ref 2025/151 regarding the Trust purchasing and supplying Paracetamol and ibuprofen
8540-My-Community-Autumn-2019-V5-ONLINE.pdf
My Community Autumn 2019
Sending information via email.docx
Accessible Information and Communication policy
Dressing Formulary and Wound Care Guidelines (G68)
The Derbyshire Wound Care and dressing formulary has been revised in collaboration with the East Midlands Wound Care Formulary Group. Work has been undertaken to provide a clinically effective, appropriate and cost effective choices of products to manage the vast majority of wounds. The formulary is available for all practitioners working for Derbyshire Community Health Services and Primary Care Services. It is expected that prescribers will preferentially use the products listed in the guide for routine use and be able to provide robust rationale where they have prescribed outside the formulary.